Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia

Buesche, G; Freund, M; Hehlmann, R; Georgii, A; Ganser, A; Hecker, H; Heimpel, Hermann; Fonatsch, C; Heinze, B; Pfirrmann, M; Holgado, S; Schmeil, A; Tobler, A; Hasford, J; Buhr, T; Kreipe, HH; German CML Study Grp

Erstveröffentlichung

2004

Metadata only
Search for full text

Wissenschaftlicher Artikel

Autoren

Buesche, G

Freund, M

Hehlmann, R

Georgii, A

Ganser, A

et al.

Institutionen

UKU. Klinik für Innere Medizin III

Erschienen in

Leukemia ; 18 (2004), 9. - S. 1460-1467. - ISSN 0887-6924

Link zur Veröffentlichung

https://dx.doi.org/10.1038/sj.leu.2403451

Schlagwörter

chronic myeloid leukemia; bone marrow biopsies; myelofibrosis; interferon-alpha; cytosine arabinoside; chronic myelogenous leukemia; chronic granulocytic-leukemia; stain-measured fibrosis; anti-fibrogenic factor; imatinib mesylate; prognostic-significance; chronic-phase; ara-c; therapy

DDC-Sachgruppe

DDC 610 / Medicine & health

Metadata

Zur Langanzeige